Proton therapy advancement

Bijan Arjomandy

Abstract


The benefit of proton therapy over conventional photon and electron therapies has been recognized in the past few decades. The physical characteristics of proton beams are exploited to enhance the dose to the target and to reduce the dose to healthy tissues. It has been shown that there is a great advantage in using proton therapy for treatment of medulloblastoma, lung, head and neck, gastrointestinal, and other sites. The innovation in proton therapy equipment has and will help to reduce the cost of acquiring this modality and will enable many cancer centers to employ this technique to their current practice for cancer patients’ treatment. It is foreseen that this methodology will be a common practice in almost all the cancer centers in the US and abroad as intensity modulated radiotherapy is currently. 


Keywords


Proton Therapy, New Modality, Radiotherapy, IMPT

Full Text:

PDF HTML

References


Coutrakon GB. Accelerators for heavy-charged-particle radiation therapy. Technol Cancer Res Treat 2007;649-54.

Cox J. Current and future status of proton-beam radiation therapy in radiation oncology. Clinical Advances in Hematology & Ooncology 2007;5: 303-5.

Jakel O, Schulz-Ertner D, Karger CP, et al. Heavy Ion Therapy: Status and Perspectives. Technol Cancer Res Treat 2003;2:377-87.

Maughan RL, Farr JB. Proton and charged particle radiotherapy. Wolters Kluwer Health/Lippincott Williams. Philadelphia: Wilkins; 2008.

Miller DW. A review of proton beam radiation therapy. Med Phys 1995;22:1943-54.

Smith AR. Proton therapy. Phys Med Biol 2006;51:R491-504.

Tsujii H. [The present and future of heavy charged particle therapy]. Nihon Rinsho. Japanese Journal of clinical Medicine 1996;54:268-73.

Available from: http://www.ptcog.ch/index.php/facilities-in-operation (Particle Therapy Co-Operative Group). Switzerland: 2013.

Wilson RR. Radiological use of fast protons. Radiology 1946;47:487-91.

Lawrence JH, Tobias CA, Born JL, et al. Pituitary irradiation with high-energy proton beams: a preliminary report. Cancer Research 1958;18:121-34.

Larsson B, Leksell L, Rexed B, et al. The high-energy proton beam as a neurosurgical tool. Nature 1958;182:1222-3.

Kjellberg RN, Sweet WH, Preston WM, et al. The Bragg peak of a proton beam in intracranial therapy of tumors. Transactions of the American Neurological Association 1962;87:216-8.

Paganetti H. Proton Therapy Physics. Boca Raton, FL: CRC Press/Taylor & Francis; 2012.

Linz U. Ion beam therapy. New York: Springer; 2011.

Ma C, Lomax T. Proton and carbon ion therapy. Boca Raton: Taylor & Francis; 2013.

Breuer H, Smit BJ. Proton Therapy and Radiosurgery. Berlin, Heidelberg: Springer Berlin Heidelberg; 2000.

International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting proton-Beam Therapy. Journal of the International Commission on Radiation Units (ICRU). Glasglow, UK: Oxford University Press; 2007.

Wambersie A, Gregroire V, Brucher J. Potential clinical gain of proton (and heavy ion) beams for brain tumors in children. Int J Radiat Oncol Biol Phys 1992;22:275-86.

Paganetti H. Significance and implementation of RBE variations in proton beam therapy. Technol Cancer Res Treat 2003;2:413-26.

Cianchetti M, Amichetti M. Sinonasal malignancies and charged particle radiation treatment: a systematic literature review. Int J Otolaryngol 2012;2012:325891.

Brown A, Suit H. The centenary of the discovery of the Bragg peak. Radiother Oncol 2004;73:265-8.

International Commission on Radiation Units and Measurements. Stopping powers and ranges for protons and alpha particles. ICRU. Bethesda, MD;1993.

International Commission on Radiation Units and Measurements. Nuclear data for neutron and proton radiotherapy and for radiation protection. ICRU. Bethesda, MD; 2000.

Durante M, Loeffler JS. Charged particles in radiation oncology. Nat Rev Clin Oncol 2009;7: 37-43.

DeLaney TF, Kooy HM. Proton and charged particle radiotherapy. Lippincott Williams. Philadelphia: Wilkins; 2008.

Arjomandy B, Sahoo N, Cox J, et al. Comparison of surface doses from spot scanning and passively scattered proton therapy. Phys Med Biol 2009;54:295-302.

Yan X, Titt U, Koehler, et al. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 2002;476:429-34.

Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol 1999;44: 185-205.

Lomax AJ, Bortfeld T, Goitein G, et al. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy. Radiother Oncol 1999;51:257-71.

Pedroni E, Bohringer T, Coray A, et al. Initial experience of using an active beam delivery technique at PSI. Strahlenther Onkol 1999;2:18-20.

Schaffner B, Pedroni E, Lomax A. Dose calculation models for proton treatment planning using a dynamic beam delivery system: an attempt to include density heterogeneity effects in the analytical dose calculation. Phys Med Biol 1999;44:27-41.

Allen AM, Pawlicki T, Dong L, et al. An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol 2012;103:8-11.

Fan C, Li Y, Liu Q. Advantages of proton therapy in non-small cell lung cancers. Cancer Biother Radiopharm 2013;28:183-6.

Glimelius B, Ask A, Bjelkengren G, et al. Number of patients potentially eligible for proton therapy. Acta Oncol 2005;44:836-49.

Lomax AJ, Boehringer T, Coray A, et al. Intensity modulated proton therapy: a clinical example. Med Phys 2001;28:317-24.

Rossi CJ. Conformal proton beam therapy of prostate cancer--update on the Loma Linda University medical center experience. Strahlenther Onkol 1999;175:82-4.

Slater JD, Rossi Jr CJ, Yonemoto LT, et al. Proton therapy for prostate cancer: the initial Loma Linda University experience. Int J Radiat Oncol Biol Phys 2004;59:348-52.

Slater JD, Yonemoto LT, Rossi C, et al. Conformal proton therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 1998;42:299-304.

St Clair WH, Adams JA, Bues M, et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 2004;58:727-34.

Suit H, Kooy H, Trofimov A, et al. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother Oncol 2008;86:148-53.

Swanson EL, Indelicato DJ, Louis D, et al. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. Int J Radiat Oncol Biol Phys 2012;83:1549-57.

Taghian AG, Kozak KR, Katz A, et al. Accelerated partial breast irradiation using proton beams: Initial dosimetric experience. Int J Radiat Oncol Biol Phys 2006;65:1404-10.

Vargas C, Fryer A, Mahajan C, et al. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2007;70:744-51.

Vatnitsky S, Moyers M, Miller D, et al. Proton dosimetry intercomparison based on the ICRU report 59 protocol. Radiother Oncol 1999;51: 273-9.

Zietman AL, Bae K, Slater JD, et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American college of radiology 95-09. J Clin Oncol 2010;28:1106-11.

Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006;65:1-7.

Gridley DS, Grover RS, Loredo LN, et al. Proton-beam therapy for tumors of the CNS. Expert Rev Neurother 2010;10:319-30.

Hug EB. Protons versus photons: a status assessment at the beginning of the 21st Century. Radiother Oncol 2004;73:35-7.

Hug EB, Slater JD. Proton radiation therapy for chordomas and chondrosarcomas of the skull base. Neurosurg Clin N Am 2000;11:627-38.

Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005;294:1233-9.

Miralbell R, Lomax A, Bortfeld T, et al. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: reduction of the supratentorial target volume. Int J Radiat Oncol Biol Phys 1997;38:477-84.

Howell RM, Giebeler A, Koontz-Raisig W, et al. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiat Oncol 2012;7:116.

Bush DA, Slater JD, Bonnet R, et al. Proton-beam radiotherapy for early-stage lung cancer. Chest 1999;116:1313-9.

Rana S, Pokharel S, Zheng Y, et al. Treatment planning study comparing proton therapy, RapidArc and intensity modulated radiation therapy for a synchronous bilateral lung cancer case. Int J Cancer Ther Oncol 2014;2:020216.

Moyers MF, Miller DW, Bush DA, et al. Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys 2001;49:1429-38.

Bush DA, Slater JD, Shin BB, et al. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 2004;126:1198-203.

Chang JY, Liu HH, Komaki R. Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer. Curr Oncol Rep 2005;7:255-9.

Engelsman M, Kooy HM. Target volume dose considerations in proton beam treatment planning for lung tumors. Med Phys 2005;32:3549-57.

Song S, Park HJ, Yoon JH, et al. Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors. Acta Oncol 2014;53: 1158-64.

Mizumoto M, Okumura T, Hashimoto T, et al. Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys 2010;81:1039-45.

Nakayama H, Sugahara S, Fukuda K, et al. Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract. Int J Radiat Oncol Biol Phys 2011;80:992-5.

Yanazume S, Arimura T, Kobayashi H, et al. Potential proton beam therapy for recurrent endometrial cancer in the vagina. J Obstet Gynaecol Res 2014;41:813-6.

Pommier P, Liebsch NJ, Deschler DG, et al. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:1242-9.

Timmermann B. Proton beam therapy for childhood malignancies: status report. Klin Padiatr 2010;222:127-33.

Koch N, Newhauser W. Virtual commissioning of a treatment planning system for proton therapy of ocular cancers. Radiat Prot Dosimetry 2005;115:159-63.

Krengli M, Hug EB, Adams JA, et al. Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements. Int J Radiat Oncol Biol Phys 2005;61:583-93.

Newhauser WD, Burns J, Smith AR. Dosimetry for ocular proton beam therapy at the Harvard Cyclotron Laboratory based on the ICRU Report 59. Med Phys 2002;29:1953-61.

Rethfeldt C, Fuchs H, Gardey KU. Dose distributions of a proton beam for eye tumor therapy: hybrid pencil-beam ray-tracing calculations. Med Phys 2006;33:782-91.

Rundle P, Singh AD, Rennie I. Proton beam therapy for iris melanoma: a review of 15 cases. Eye (Lond) 2006;21:79-82.

Weber DC, Bogner J, Verwey J, et al. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. Int J Radiat Oncol Biol Phys 2005;63:373-84.

Höcht S, Bechrakis NE, Nausner M, et al. Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute. Strahlenther Onkol 2004;180:419-24.

Lee V, Hungerford JL. Proton beam therapy for posterior pole circumscribed choroidal haemangioma. Eye (Lond) 1998;12:925-8.

Weber DC, Bogner J, Verwey J, et al. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study. Int J Radiat Oncol Biol Phys 2005;63:373-84.

Arjomandy B. Evaluation of patient residual deviation and its impact on dose distribution for proton radiotherapy. Med Dosim 2011;36:321-9.

Smith AR. Vision 20/20: proton therapy. Med Phys 2009;36:556-68.

Snavely RA, Key MH, Hatchett SP, et al. Intense high-energy proton beams from Petawatt-laser irradiation of solids. Phys Rev Lett 2000;85: 2945-8.

Caporaso GJ, Mackie TR, Sampayan S, et al. A compact linac for intensity modulated proton therapy based on a dielectric wall accelerator. Phys Med 2008;24:98-101.




DOI: http://dx.doi.org/10.14319/jpt.11.5

Copyright (c) 2015 Bijan Arjomandy

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

-------------------------------------------

© Journal of Proton Therapy (ISSN 2469-5491)

To make sure that you can receive messages from us, please add the 'protonjournal.org' and 'protonjournal.com' domains to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', please check your 'bulk mail' or 'junk mail' folders.